275 related articles for article (PubMed ID: 7478537)
21. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B
Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831
[TBL] [Abstract][Full Text] [Related]
22. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.
Yasumoto K; Yokoyama K; Shibata K; Tomita Y; Shibahara S
Mol Cell Biol; 1994 Dec; 14(12):8058-70. PubMed ID: 7969144
[TBL] [Abstract][Full Text] [Related]
23. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation.
Albino AP; Davis BM; Nanus DM
Cancer Res; 1991 Sep; 51(18):4815-20. PubMed ID: 1716514
[TBL] [Abstract][Full Text] [Related]
24. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
25. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
26. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
27. Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.
Mahalingam H; Watanabe A; Tachibana M; Niles RM
Exp Cell Res; 1997 Nov; 237(1):83-92. PubMed ID: 9417870
[TBL] [Abstract][Full Text] [Related]
28. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors.
Smit DJ; Smith AG; Parsons PG; Muscat GE; Sturm RA
Eur J Biochem; 2000 Nov; 267(21):6413-22. PubMed ID: 11029584
[TBL] [Abstract][Full Text] [Related]
29. Role of PLZF in melanoma progression.
Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
[TBL] [Abstract][Full Text] [Related]
30. Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma.
Zhiqi S; Soltani MH; Bhat KM; Sangha N; Fang D; Hunter JJ; Setaluri V
Melanoma Res; 2004 Dec; 14(6):509-16. PubMed ID: 15577322
[TBL] [Abstract][Full Text] [Related]
31. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
Fang D; Tsuji Y; Setaluri V
Nucleic Acids Res; 2002 Jul; 30(14):3096-106. PubMed ID: 12136092
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.
Vachtenheim J; Novotna H; Ghanem G
J Invest Dermatol; 2001 Dec; 117(6):1505-11. PubMed ID: 11886515
[TBL] [Abstract][Full Text] [Related]
33. Identification of a discrete promoter region of the human GnRH gene that is sufficient for directing neuron-specific expression: a role for POU homeodomain transcription factors.
Wolfe A; Kim HH; Tobet S; Stafford DE; Radovick S
Mol Endocrinol; 2002 Mar; 16(3):435-49. PubMed ID: 11875100
[TBL] [Abstract][Full Text] [Related]
34. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
35. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
36. The Brn-2 transcription factor links activated BRAF to melanoma proliferation.
Goodall J; Wellbrock C; Dexter TJ; Roberts K; Marais R; Goding CR
Mol Cell Biol; 2004 Apr; 24(7):2923-31. PubMed ID: 15024080
[TBL] [Abstract][Full Text] [Related]
37. A melanoma octamer binding protein is responsive to differentiating agents.
Sturm RA; Bisshop F; Takahashi H; Parsons PG
Cell Growth Differ; 1991 Oct; 2(10):519-24. PubMed ID: 1751407
[TBL] [Abstract][Full Text] [Related]
38. Expression studies of pigmentation and POU-domain genes in human melanoma cells.
Sturm RA; O'Sullivan BJ; Thomson JA; Jamshidi N; Pedley J; Parsons PG
Pigment Cell Res; 1994 Aug; 7(4):235-40. PubMed ID: 7855069
[TBL] [Abstract][Full Text] [Related]
39. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture.
Herlyn M; Rodeck U; Mancianti M; Cardillo FM; Lang A; Ross AH; Jambrosic J; Koprowski H
Cancer Res; 1987 Jun; 47(12):3057-61. PubMed ID: 3034401
[TBL] [Abstract][Full Text] [Related]
40. A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.
Kwon BS; Halaban R; Kim GS; Usack L; Pomerantz S; Haq AK
Mol Biol Med; 1987 Dec; 4(6):339-55. PubMed ID: 2449595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
